发明授权
- 专利标题: HCV protease inhibitors
- 专利标题(中): HCV蛋白酶抑制剂
-
申请号: US12559818申请日: 2009-09-15
-
公开(公告)号: US08389560B2公开(公告)日: 2013-03-05
- 发明人: Chen-Fu Liu , Kuang-Yuan Lee , Pei-Chin Cheng , Yo-Chin Liu , Pin Lo , Kuo-Feng Tseng , Chih-Ming Chen , Chi-Hsin Richard King , Chu-Chung Lin
- 申请人: Chen-Fu Liu , Kuang-Yuan Lee , Pei-Chin Cheng , Yo-Chin Liu , Pin Lo , Kuo-Feng Tseng , Chih-Ming Chen , Chi-Hsin Richard King , Chu-Chung Lin
- 申请人地址: TW Taipei
- 专利权人: TaiGen Biotechnology Co., Ltd.
- 当前专利权人: TaiGen Biotechnology Co., Ltd.
- 当前专利权人地址: TW Taipei
- 代理机构: Occhiuti Rohlicek & Tsao LLP
- 主分类号: A61K31/407
- IPC分类号: A61K31/407 ; C07D245/04 ; C07D401/12
摘要:
This invention relates to macrocyclic compounds of formula (I) shown in the specification. These compounds can be used to treat hepatitis C virus infection.
公开/授权文献
- US20110065737A1 HCV PROTEASE INHIBITORS 公开/授权日:2011-03-17